This page has moved. Click here to view.
Physicians' Drug Reference
New Warnings. Medical Library. Full Text Journals Medical Books Online.
Aseptic meningitis outbreak linked to widespread MMR vaccination
Her2/Neu vaccination prevents progression of DCIS to invasive cancer in mice
Meningitis C vaccine
Cannabinoids reduce MS symptoms in animal model
Low-dose estrogen plus gestodene or desogestrel provide good cycle control
Zafirlukast effect less marked in elderly asthmatics
ephedra proposal
Hybrid cell vaccination a promising new cancer immunotherapy
HAART use correlates with reductions in HIV-related GI disorders
Salmeterol and fluticasone mixture effective in asthma therapy
Alexion C5 inhibitor gets fast-track status
Solvay gets US approval of testosterone gel
FDA approves new dosage of allergy medication
Sicor antihypertensive approved by FDA
Ariad's graft-versus-host treatment gets orphan drug status
Ivax gets supplemental approval of generic Darvocet-N
Orphan drug status granted to malignant melanoma treatment
Pneumococcal vaccine Prevnar approved for children under 2
FEB 10, 2000 Lotronex (alosetron)
FEB 02, 2000 Protonix (pantoprazole sodium)
01, 2000 Phenobarbital for cerebral malaria associated with "unacceptable" mortality
FEB 28, 2000 Sumatriptan use linked to preterm delivery
FEB 25, 2000 FDA continues to monitor Rezulin reports
FEB 24, 2000 Fluconazole use in the ICU is associated with negative patient outcomes and unfavorable microbial trends
FEB 21, 2000 Patient prescription misunderstandings arise from lack of participation
FEB 21, 2000 Arthritis is a potential side effect of clopidogrel
FEB 11, 2000 Drug interactions involving St. John's wort reported
FEB 08, 2000 Intranasal beclomethasone dipropionate slows the growth rate of prepubertal children
FEB 14, 2000 Actimmune Injection (interferon gamma-1b) Received orphan-drug approval for the indication of the rare congenital disorder osteopetrosis
FEB 04, 2000 Levaquin (Levofloxacin Tablets/Injection) Approved for the treatment of penicillin-resistant Streptococcus pneumoniae in patients with community acquired pneumonia
DEC 23, 2002 Celebrex (celecoxib) Approved for patients with familial adenomatous polyposis
DEC 23, 2002 Taxotere (docetaxel) Approved for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy.
DEC 15, 2002 Carnitor Injection (levocarnitine) Approved for the treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis
DEC 14, 2002 Engerix-B (Hepatitis B Vaccine, Recombinant) Approved for preventing hepatitis B infections which can lead to primary liver cancer
DEC 07, 2002 Zoloft (sertraline hydrochloride) Approved for the treatment of post traumatic stress syndrome
NOV 29, 2002 Viracept (nelfinavir mesylate) Twice-daily dosing approved by FDA
NOV 10, 2002 Remicade (infliximab) Approved for rheumatoid arthritis
NOV 03, 2002 Epogen (epoetin alfa) Approved for pediatric use
03, 2000 Ilex Oncology buys British Biotech's US operations
03, 2000 PathoGenesis, AeroGen to collaborate on cystic fibrosis drug delivery
03, 2000 Hollis-Eden licenses patent series from Humanetics
03, 2000 Mylan settles patent dispute with Pfizer over nifedipine
02, 2000 Chiron gets vaccine patent; stock rises on buy rating
02, 2000 Bioject signs supply deal with Amgen
02, 2000 Isis shares rise on initiation of phase I/II studies of hepatitis C drug
02, 2000 Millennium receives US patent for Melastatin gene
02, 2000 GMP to fund diabetes research efforts
01, 2000 Myogen, UT Southwestern Medical to collaborate on heart failure therapeutics
01, 2000 Cell Pathways, Lilly to study combined anticancer drugs
01, 2000 Isis receives patent on antisense technology
JAN 17, 2000 Trileptal (oxcarbazepine) Approved for the treatment of partial seizures in adults and children as young as four years of age
DEC 30, 2002 Targretin (bexarotene) Approved for once-daily treatment of cutaneous manifestations of cutaneous T-cell lymphoma
DEC 21, 2002 Tequin (gatifloxacin) Indicated for the treatment of infections
DEC 13, 2002 Avelox (moxifloxacin HCl) A new quinolone antibiotic
DEC 02, 2002 Keppra (Levetiracetam) Approved for adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy
NOV 24, 2002 Aggrenox (Aspirin/Extended-Release Dipyridamole) Approved for the prevention of secondary stroke and transient ischemic attacks
OCT 28, 2002 Niaspan (niacin) New indication approved for dyslipidemia
OCT 25, 2002 Aromasin (exemestane) Approved for the treatment of advanced breast cancer in postmenopausal women
OCT 21, 2002 Comtan (entacapone) Approved as an adjunctive treatment for patients with idiopathic Parkinson's disease
OCT 06, 2002 Tikosyn (dofetilide) Approved for the maintenance and conversion of normal sinus rhythm in patients with highly symptomatic atrial fibrillation and/or atrial flutter
OCT 05, 2002 Rhinocort Aqua nasal spray (budesonide) Approved for the management of nasal symptoms of allergic rhinitis in adults and children six years of age and older
OCT 04, 2002 Evista (raloxifene) New indication approved for the treatment of postmenopausal osteoporosis
SEP 22, 2002 Accolate (zafirlukast) Approved for asthma therapy in younger children
AUG 27, 2002 Repronex (menotropins for SQ injection) Approved for self-administered subcutaneous injection
AUG 16, 2002 Cleocin Vaginal Ovules (clindamycin phosphate) Approved for use in non-pregnant women as a 3-day treatment of bacterial vaginosis
AUG 13, 2002 Sonata (zaleplon) Approved for insomnia treatment
AUG 05, 2002 Zocor (simvastatin) New Indication approved as an adjunct to diet for increasing HDL in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb)
JUL 30, 2002 Vestra (reboxetine mesyiate) For use in the treatment of depression
JUL 27, 2002 Kytril (granisetron) New indication for nausea in patients undergoing radiation
JUL 23, 2002 Topamax (topiramate) As adjunctive therapy in pediatric patients ages 2 - 16 years with partial onset seizures
JUL 14, 2002 Plan B (levonorgestrel) The first progestin-only emergency contraceptive pill
JUN 29, 2002 Doxil (doxorubicin) Approved for use in women with ovarian cancer refractory to paclitaxel- and platinum-based chemotherapy regimens
JUN 11, 2002 Hectorol (doxercalciferol) Approved for the treatment of secondary hyperparathyroidism in patients undergoing chronic renal dialysis
APR 01, 2002 Humate-P (Antihemophilic Factor) New Indication in von Willebrand's disease
30, 2002 Sporanox Injection (itraconozole) Approved for several difficult-to-treat, potentially life-threatening fungal infections
26, 2002 NovoSeven (recombinant human coagulation Factor VIIa) Indicated
Her2/Neu vaccination prevents progression of DCIS to invasive cancer in mice
Meningitis C vaccine
Cannabinoids reduce MS symptoms in animal model
Low-dose estrogen plus gestodene or desogestrel provide good cycle control
Zafirlukast effect less marked in elderly asthmatics
ephedra proposal
Hybrid cell vaccination a promising new cancer immunotherapy
HAART use correlates with reductions in HIV-related GI disorders
Salmeterol and fluticasone mixture effective in asthma therapy
Alexion C5 inhibitor gets fast-track status
Solvay gets US approval of testosterone gel
FDA approves new dosage of allergy medication
Sicor antihypertensive approved by FDA
Ariad's graft-versus-host treatment gets orphan drug status
Ivax gets supplemental approval of generic Darvocet-N
Orphan drug status granted to malignant melanoma treatment
Pneumococcal vaccine Prevnar approved for children under 2
FEB 10, 2000 Lotronex (alosetron)
FEB 02, 2000 Protonix (pantoprazole sodium)
01, 2000 Phenobarbital for cerebral malaria associated with "unacceptable" mortality
FEB 28, 2000 Sumatriptan use linked to preterm delivery
FEB 25, 2000 FDA continues to monitor Rezulin reports
FEB 24, 2000 Fluconazole use in the ICU is associated with negative patient outcomes and unfavorable microbial trends
FEB 21, 2000 Patient prescription misunderstandings arise from lack of participation
FEB 21, 2000 Arthritis is a potential side effect of clopidogrel
FEB 11, 2000 Drug interactions involving St. John's wort reported
FEB 08, 2000 Intranasal beclomethasone dipropionate slows the growth rate of prepubertal children
FEB 14, 2000 Actimmune Injection (interferon gamma-1b) Received orphan-drug approval for the indication of the rare congenital disorder osteopetrosis
FEB 04, 2000 Levaquin (Levofloxacin Tablets/Injection) Approved for the treatment of penicillin-resistant Streptococcus pneumoniae in patients with community acquired pneumonia
DEC 23, 2002 Celebrex (celecoxib) Approved for patients with familial adenomatous polyposis
DEC 23, 2002 Taxotere (docetaxel) Approved for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy.
DEC 15, 2002 Carnitor Injection (levocarnitine) Approved for the treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis
DEC 14, 2002 Engerix-B (Hepatitis B Vaccine, Recombinant) Approved for preventing hepatitis B infections which can lead to primary liver cancer
DEC 07, 2002 Zoloft (sertraline hydrochloride) Approved for the treatment of post traumatic stress syndrome
NOV 29, 2002 Viracept (nelfinavir mesylate) Twice-daily dosing approved by FDA
NOV 10, 2002 Remicade (infliximab) Approved for rheumatoid arthritis
NOV 03, 2002 Epogen (epoetin alfa) Approved for pediatric use
03, 2000 Ilex Oncology buys British Biotech's US operations
03, 2000 PathoGenesis, AeroGen to collaborate on cystic fibrosis drug delivery
03, 2000 Hollis-Eden licenses patent series from Humanetics
03, 2000 Mylan settles patent dispute with Pfizer over nifedipine
02, 2000 Chiron gets vaccine patent; stock rises on buy rating
02, 2000 Bioject signs supply deal with Amgen
02, 2000 Isis shares rise on initiation of phase I/II studies of hepatitis C drug
02, 2000 Millennium receives US patent for Melastatin gene
02, 2000 GMP to fund diabetes research efforts
01, 2000 Myogen, UT Southwestern Medical to collaborate on heart failure therapeutics
01, 2000 Cell Pathways, Lilly to study combined anticancer drugs
01, 2000 Isis receives patent on antisense technology
JAN 17, 2000 Trileptal (oxcarbazepine) Approved for the treatment of partial seizures in adults and children as young as four years of age
DEC 30, 2002 Targretin (bexarotene) Approved for once-daily treatment of cutaneous manifestations of cutaneous T-cell lymphoma
DEC 21, 2002 Tequin (gatifloxacin) Indicated for the treatment of infections
DEC 13, 2002 Avelox (moxifloxacin HCl) A new quinolone antibiotic
DEC 02, 2002 Keppra (Levetiracetam) Approved for adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy
NOV 24, 2002 Aggrenox (Aspirin/Extended-Release Dipyridamole) Approved for the prevention of secondary stroke and transient ischemic attacks
OCT 28, 2002 Niaspan (niacin) New indication approved for dyslipidemia
OCT 25, 2002 Aromasin (exemestane) Approved for the treatment of advanced breast cancer in postmenopausal women
OCT 21, 2002 Comtan (entacapone) Approved as an adjunctive treatment for patients with idiopathic Parkinson's disease
OCT 06, 2002 Tikosyn (dofetilide) Approved for the maintenance and conversion of normal sinus rhythm in patients with highly symptomatic atrial fibrillation and/or atrial flutter
OCT 05, 2002 Rhinocort Aqua nasal spray (budesonide) Approved for the management of nasal symptoms of allergic rhinitis in adults and children six years of age and older
OCT 04, 2002 Evista (raloxifene) New indication approved for the treatment of postmenopausal osteoporosis
SEP 22, 2002 Accolate (zafirlukast) Approved for asthma therapy in younger children
AUG 27, 2002 Repronex (menotropins for SQ injection) Approved for self-administered subcutaneous injection
AUG 16, 2002 Cleocin Vaginal Ovules (clindamycin phosphate) Approved for use in non-pregnant women as a 3-day treatment of bacterial vaginosis
AUG 13, 2002 Sonata (zaleplon) Approved for insomnia treatment
AUG 05, 2002 Zocor (simvastatin) New Indication approved as an adjunct to diet for increasing HDL in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb)
JUL 30, 2002 Vestra (reboxetine mesyiate) For use in the treatment of depression
JUL 27, 2002 Kytril (granisetron) New indication for nausea in patients undergoing radiation
JUL 23, 2002 Topamax (topiramate) As adjunctive therapy in pediatric patients ages 2 - 16 years with partial onset seizures
JUL 14, 2002 Plan B (levonorgestrel) The first progestin-only emergency contraceptive pill
JUN 29, 2002 Doxil (doxorubicin) Approved for use in women with ovarian cancer refractory to paclitaxel- and platinum-based chemotherapy regimens
JUN 11, 2002 Hectorol (doxercalciferol) Approved for the treatment of secondary hyperparathyroidism in patients undergoing chronic renal dialysis
APR 01, 2002 Humate-P (Antihemophilic Factor) New Indication in von Willebrand's disease
30, 2002 Sporanox Injection (itraconozole) Approved for several difficult-to-treat, potentially life-threatening fungal infections
26, 2002 NovoSeven (recombinant human coagulation Factor VIIa) Indicated